CN Patent

CN114605391B — 喹喔啉类衍生物及其制备方法和应用

Assigned to Beike Huaxia Biomedical Technology Co ltd · Expires 2024-01-26 · 2y expired

What this patent protects

本发明涉及一种具有如式(I)所示结构的喹喔啉类衍生物、或其盐、或其药学上可接受的载体。该喹喔啉类化合物具有AXL和c‑Met双效激酶抑制活性，能够发挥较好的抗肿瘤功效，同时还具有良好的安全性和耐受性。

USPTO Abstract

本发明涉及一种具有如式(I)所示结构的喹喔啉类衍生物、或其盐、或其药学上可接受的载体。该喹喔啉类化合物具有AXL和c‑Met双效激酶抑制活性，能够发挥较好的抗肿瘤功效，同时还具有良好的安全性和耐受性。

Drugs covered by this patent

cabozantinib-s-malate (CABOZANTINIB S-MALATE)

Patent Metadata

Patent number: CN114605391B
Jurisdiction: CN
Classification: —
Expires: 2024-01-26
Drug substance claim: No
Drug product claim: No
Assignee: Beike Huaxia Biomedical Technology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.